14 PhD Positions in the EU Horizon 2020 MSCA-ITN project V.A. Cure
Vascular anomalies (VAs) are a group of rare diseases defined by blood- or lymph vessel dysfunction causing chronic pain, disabilities, and even sudden death, for which effective treatments are lacking. The V.A. Cure network aims to uncover core mechanisms of initiation and maintenance of these diseases with the final goal to stablish novel therapeutic strategies for VAs. The network is funded in the frame of the EU MSCA-ITN programme and has 9 consortium partners:
de Duve Institute (Belgium) – Uppsala University (Sweden) – Karolinska Institute (Sweden) – Potsdam University (Germany) – Max Planck Institute for Heart and Lung Research (Germany) – Oulu University (Finland) – INSERM U136 Grenoble (France) – FinnAdvance (Finland) – AstraZeneca (Sweden)
Working at one of the partners and being part of a team of 14 Early Stage Researchers (ESRs), you will be enrolled in a PhD programme and work on one of the research projects listed below. You will receive training in the fundamentals of vascular biology and state-of-the-art biomedical research techniques, as well as in generic skills like management and communication through the network’s international training programme. You will take part in networking and outreach events of the network. For short periods (several months), you will work at other universities or companies of the network.
To qualify as a candidate, you must:
Benefits of joining the V.A. Cure Network:
Salary and appointment terms
The successful candidates will receive an attractive salary (gross salary 3.171 – 3.983 euro depending on the country), in accordance with the MSCA regulations for Early Stage Researchers. The period of employment is 3 or 4 years depending on the institution (ITN funding for first 3 years).
How to apply
You may apply for one to max 4 research project(s) (see below). If you apply for more than one project, please indicate your order of preference.
1. Make sure you meet the qualifying requirements!
2. Submit your application to email@example.com by e-mail. Please send one pdf file containing:
For position ESR 6 the application should also be submitted via the Varbi recruitment system of Karolinska Institutet.
For positions ESR 4 and ESR 7 your application must also be submitted to Uppsala University via a web form that is accessible through this link.
Only position ESR 11 is still open for applications until 30 June. The deadline for submitting applications for the other positions has passed.
The network consortium will make a shortlist for each position. Shortlisted candidates will be interviewed (face-to-face or via teleconferencing) by three consortium members. Final selection may involve an additional face-to-face interview. All interviews will be held in English. Calendar:
Application deadline: 30 June 2019 (position ESR 11)
Interviews: April – August 2019
Aimed start date: June – October 2019
For more information see Recruitment process and selection criteria.
Please visit www.vacure.eu for more information on the project, the recruitment and selection criteria.
ESR 1 & 2: Identification of novel genes that cause Vascular Anomalies (de Duve Institute)
ESR 4: Generation and characterization of mouse models for Venous Malformation and Lymphatic Malformation (Uppsala University)
ESR 5: iPS cells for vascular anomaly research (AstraZeneca)
ESR 6: Cellular heterogeneity in vascular malformation ‐ identification of novel targets (Karolinska Institute)
ESR 9 & 10: Zebrafish models of vascular development and disease (Potsdam University)
ESR 11: Dissecting the role of FOXO transcription factors in venous and lymphatic malformations (Max Planck Institute for Heart and Lung Research)
ESR 12: Respective roles of BMP9 and BMP10 in blood and lymphatic vascular homeostasis (INSERM U136 Grenoble)
ESR 13: BMP9/10 non-Smad signalling pathways: new targets for HHT treatment? (INSERM U136 Grenoble)
ESR 14: Vascular anomaly-On-A-Chip (FinnAdvance)